The Impact of a Topical Vasodilating Cream on Female Sexual Experience (TVConFSD)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.

Verified March 2012 by Michael Pelekanos MD, East Suburban Ob Gyn.
Recruitment status was: Recruiting

Sponsor:

Collaborator:

West Penn Allegheny Health System

Information provided by (Responsible Party):

Michael Pelekanos MD, East Suburban Ob Gyn

ClinicalTrials.gov Identifier:

NCT01078077

First received: March 1, 2010

Last updated: March 1, 2012

Last verified: March 2012

History of Changes

Purpose

The purpose of this study is to determine if a topical vasodilating cream will improve female sexual experience.

Condition
Female Sexual Dysfunction


Study Type:	Observational
Study Design:	Observational Model: Case Control Time Perspective: Prospective
Official Title:	The Impact of a Topical Vasodilating Cream (When Applied to the Clitoris) on the Female Sexual Experience Using a Standard 7 Part Female Sexual Dysfunction Questionnaire

Further study details as provided by Michael Pelekanos MD, East Suburban Ob Gyn:


Estimated Enrollment:	200
Study Start Date:	March 2010
Estimated Study Completion Date:	July 2012
Primary Completion Date:	March 2012 (Final data collection date for primary outcome measure)

Detailed Description:

To determine in a placebo controlled double blinded study whether a topically applied vasodilating cream will improve the female sexual response as measured by a standard female sexual dysfunction questionnaire

Eligibility


Ages Eligible for Study:	25 Years to 60 Years (Adult)
Sexes Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

Sexually active females from ages 25 to sixty not on SSRI's without neurologic disease able sign and understand informed consent

Criteria

Inclusion Criteria:

Healthy females ages 25 to sixty sexually active

Exclusion Criteria:

Neurologic disease, on SSRI's,advanced diabetes, non sexually active, mentally incompetent

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01078077

Contacts


Contact: michael j pelekanos, MD	4128567500	mipels@aol.com
Contact: Guy Stofman, MD	4123706313	guystof@aol.com

Locations


United States, Pennsylvania
East Suburban Obgyn	Recruiting
Monroeville, Pennsylvania, United States, 15146
Contact: Michael J Pelekanos, MD 412-779-1034 mipels@aol.com
Contact: Guy Stoffman, MD 412 3706313 guystof@aol.com
Principal Investigator: Michael J Pelekanos, MD
West Penn Allegheny Health Center	Recruiting
Monroeville, Pennsylvania, United States, 15146
Contact: pelekanos 412-856-7500
Contact: vickie lathom 4128567500
Principal Investigator: michael j pelekanos, md
West Penn Hospital Forbes Campus	Recruiting
Monroeville, Pennsylvania, United States, 15146
Contact: michael j pelekanos, md 412-856-7500 mipels@aol.com
Principal Investigator: michael j pelekanos, md

Sponsors and Collaborators

Michael Pelekanos MD

West Penn Allegheny Health System

Investigators


Principal Investigator:	michael j pelekanos, MD	east surburban obgyn

More Information


Responsible Party:	Michael Pelekanos MD, michael pelekanos MD, WPAHS, East Suburban Ob Gyn
ClinicalTrials.gov Identifier:	NCT01078077 History of Changes
Other Study ID Numbers:	10-005
Study First Received:	March 1, 2010
Last Updated:	March 1, 2012

Keywords provided by Michael Pelekanos MD, East Suburban Ob Gyn:


healthy females ages twentyfive through sixty

ClinicalTrials.gov processed this record on June 23, 2017

To Top